The Pfizer Foundation announces $5 million in grants to support women and families

PfizerThe Pfizer Foundation announced a new $5 million grant commitment to initiatives in low- and middle-income countries that provide family planning access and education for women and men at the same time children are routinely vaccinated. These new grants build on The Pfizer Foundation's existing grant program by providing a second round of funding to international nongovernmental organizations (INGOs) in five African countries where different barriers exist for women to access family planning services, bringing the total program funding to $11.7 million to date.

"At Pfizer, we support the belief that women around the world should have access to family planning services and information so that they can make informed decisions that are appropriate for their needs," said Caroline Roan, President of The Pfizer Foundation. "We are proud to be expanding The Pfizer Foundation’s support of this innovative approach to family planning, making it easier for underserved women to access family planning services at the same time their children receive critical immunizations to protect them against disease."

As of 2017, an estimated 214 million women and girls who wanted to delay or avoid pregnancy were still without access to modern contraception, and the proportion of women with the highest unmet need was in Sub-Saharan Africa (21 percent).(1)

Through each of the four initiatives in five countries (Benin, Ethiopia, Kenya, Malawi and Uganda), The Pfizer Foundation aims to create opportunities for women and men to access family planning services and information, while reducing the number of clinic visits and increasing health system efficiency. These projects include:

An initiative with Save the Children to increase access to quality integrated childhood immunization and family planning services for women and children in three districts of southern Malawi by strengthening the quality of services at integrated outreach clinics, provider training and advocacy meetings with community leaders.

A partnership with the International Rescue Committee to increase integrated family planning and immunization service access, quality and demand in Ethiopia and Uganda that also engages men through community education.

An initiative with World Vision to increase voluntary use of modern family planning methods and immunization through an integrated delivery model in two Kenyan counties with poor maternal and child health. The strategic focus is on mobilizing community health workers, traditional leaders and faith leaders to increase knowledge of the maternal and child health benefits of healthy timing and spacing of pregnancies.

A program with CARE to improve family planning counseling and clinical skills of healthcare providers while addressing reasons women avoid seeking contraception in Benin, where more than one-third of women have an unmet need for family planning services.(2) Among the reasons women avoid family planning are misconceptions about impact on their health or social stigma of being unmarried.

"We've seen the significant potential to increase uptake of family planning among women who previously may not have had access to these integrated services," said Jodi Nelson, Senior Vice President, Policy and Practice, the International Rescue Committee. "This new grant from The Pfizer Foundation will enable us to further expand the scale and scope of the program, while also improving the quality of services in partnership with the local communities and health providers in Ethiopia and Uganda."

An evaluation, conducted by the London School of Hygiene and Tropical Medicine, is currently ongoing to better understand what drives the effective integration of immunization and family planning services at each of the four partner INGOs. Insights from this evaluation, which will be published in the fall of 2018 and presented at the International Conference on Family Planning in November in Rwanda, will be used to refine the implementation of these integrated services in the new grant period and potentially inform future funding and programs.

About The Pfizer Foundation

The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions. The Foundation's mission is to promote access to quality healthcare, to nurture innovation, and to support the community involvement of Pfizer colleagues.

1. Adding It Up: Investing in Contraception and Maternal and Newborn Health, 2017, Guttmacher Institute https://www.guttmacher.org/fact-sheet/adding-it-up-contraception-mnh-2017
2. Family Planning 2020. "Benin: FP2020 Core Indicator Summary Sheet: 2017." Accessed May 8, 2018 from http://www.track20.org/download/pdf/2017%20FP2020%20CI%20Handouts/english/Benin%202017%20FP2020%20Cor

Most Popular Now

Bayer Thrombosis Research Award 2019 goes to Dr. C…

The fourth winner of the Bayer Thrombosis Research Award has been chosen. The Scientific Committee of the Bayer Science & Education Foundation awarded the EUR 30,000 priz...

Roche enters into definitive merger agreement to a…

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) have entered into a definitive merger agreement for Roche to fully acquire Spark Therapeuti...

Brilinta’s Phase III THEMIS trial met primary endp…

The Phase III THEMIS trial met its primary endpoint and demonstrated that Brilinta (ticagrelor), taken in conjunction with aspirin, showed a statistically-significant red...

Protein content as a marker for response to therap…

Brain tumors vary widely in how they respond to treatment. However, early assessment of therapy response is essential in order to choose the best possible treatment for t...

Jury upholds Amgen's patents on Repatha® (evolocum…

Amgen (NASDAQ:AMGN) announced that a Delaware jury delivered a verdict in Amgen's favor upholding the validity of two Amgen patents related to PCSK9 antibodies. These pat...

Artificial lung cancer tissue could help find new …

A 3D hydrogel created by researchers in U of T Engineering Professor Molly Shoichet's lab is helping University of Ottawa researchers to quickly screen hundreds of potent...

Could medical marijuana help grandma and grandpa w…

Medical marijuana may bring relief to older people who have symptoms like pain, sleep disorders or anxiety due to chronic conditions including amyotrophic lateral scleros...

New treatment offers potentially promising results…

A pioneering clinical trials program that delivered an experimental treatment directly to the brain offers hope that it may be possible to restore the cells damaged in Pa...

Amgen, Cytokinetics and Servier announce start of …

Amgen (NASDAQ: AMGN), Cytokinetics, Incorporated (NASDAQ: CYTK) and Servier today announced that METEORIC-HF (Multicenter Exercise Tolerance Evaluation of Omecamtiv Mecar...

Could blockchain ensure integrity of clinical tria…

UC San Francisco researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data with blockchain. The system creates an immutable au...

Novartis data confirm rapid response and high effi…

Novartis announced today new data in 441 Chinese patients with moderate to severe plaque psoriasis from a Phase III study investigating the efficacy and safety of Cosenty...

Abbott and Novo Nordisk enter partnership to provi…

Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly...